How eCOA Improves Patient Experience and Data Quality

With the rising demand for improving patient safety in clinical trials, the adoption of patient-centric solutions is considered the best route to enhance data accuracy and experience automated workflows

SHARE THIS POST :
How eCOA Improves Patient Experience and Data Quality

With the rising demand for improving patient safety in clinical trials, the adoption of patient-centric solutions is considered the best route to enhance data accuracy and experience automated workflows. This is where eCOA comes into play. In this blog post, we will find out how electronic clinical outcome -essments are helping the clinical trials industry handle the ever-growing list of patient data and, at the same time, reduce patient burden!

What is eCOA?

Electronic clinical outcome -essment (eCOA) refers to the process of leveraging technology to better capture data and enhanced Clinical Outcome -essment (COA). Using devices like smartphones, tablets, and personal computers, eCOA allows patients and clinicians to report regular symptomatologie’s directly into a cloud system. It records the patient’s body functioning, alerts them to make a diary entry, and improves the understanding of the patient’s experience. Moreover, it also measures the efficacy of a health intervention conducted by CROs worldwide. .

eCOA system technologies are often used by clinical trial patients to remotely send Electronic patient-reported outcome (ePRO) experience and symptoms directly to site staff. s Data gathered by an ePRO include patient-provided information about symptoms, side effects, drug timing, and questions during the clinical trial that can be tracked on any electronic device.

According to a recent study published on the Data Bridge Market Research website, the Global Electronic Clinical Outcome -essment (eCOA) market is projected to grow 16.30% from 2022 to 2029, to a whopping $4.08 billion, thanks to the enhanced protocol adherence, lowered trial risks and -ured patient safety and parti-tion that eCOA has to offer.

As a drug enters the market, it is imperative to understand how they impact patients and their health profiles. eCOA tracks health behaviours like information on exercise, smoking, and drinking. It -esses patients’ responses to monitor health behaviours over time. Let’s find out the top advantages of using eCOA in conjunction with quan-ive clinical data to determine patients’ experience with a disease and treatment more accurately.